ConductScience.org, home

Gene · 1364

NIH grants1,708

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCLDN4 papersNewest fiscal year
P50CA236733Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer22025
P51OD011092Support for National Primate Research Center22025
R01CA207295DNA damaging therapy and immune response in small cell lung cancer subtypes22025
R01DK048370Small GTP Binding Proteins in Gastrointestinal Mucosa22025
R01DK091281A Novel Role for PTPN2 in Intestinal Epithelial Barrier Regulation22025
R01HL145372Spatiotemporal genomic regulation of disease initiation and progression in pulmonary fibrosis22025
R01HL145408Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular Targets22025
R01HL158979Regulation of epithelial function using targeted nanowires22025
R35GM127087The Evolution of Gene Regulation and Human Disease22025
T32AI089474Immunology Training Program-Predoctoral22025
T32AR060710Post Graduate Program in Cutaneous Biology22025
T32CA009056Tumor Cell Biology Training Program22025
T32CA106183Surgical Oncology Training Grant22025
U01AI152011Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD Patients22025
U01CA200468Clinical Validation Center for Early Detection of Pancreatic Cancer22025
U54CA221704TUFCCC/HC Regional Comprehensive Cancer Health Partnership22025
U54CA221705TUFCCC/HC Regional Comprehensive Cancer Health Partnership22025
U54GM104940Louisiana Clinical and Translational Science Center22025
ZIAAA000036Alcohol Metabolism, Functional Consequences, Apoptosis Signaling Pathways, and Organ Damage22025
ZIAAI001222Characterization of the cellular and molecular bases of inborn errors of immunity22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1364/grants?page=4